$MBX
MBX Biosciences, Inc.
Nasdaq · Healthcare · Pharmaceutical Preparations · Carmel, IN
MBX chart
What traders are saying about $MBX
Latest postsMBX Biosciences, Inc. news
- Citizens reiterates Market Outperform on MBX Biosciences stock By Investing.com
Investing.com Canada ·
- MBX Biosciences (MBX) Reiterated at Market Outperform by Citizens on Encouraging MBX 4291 Ph1 Data
StreetInsider ·
- Form 8K MBX Biosciences Inc For: 22 October By Investing.com
Investing.com South Africa ·
- Mbx Biosciences, Inc. Announces Appointment of Peter Radovich as Director, Effective October 20, 2026
www.marketscreener.com ·
- Form 4 MBX Biosciences Inc: Peter Radovich (Director) For: 20 October
Investing.com Canada ·
- An 18,200-share option grant at MBX Biosciences (MBX) has a $53.50 exercise price.
Stock Titan ·
- MBX Biosciences appoints Peter Radovich to its board
TradingView ·
- The board is set at eight as MBX Biosciences (MBX) appoints Peter Radovich.
Stock Titan ·
- Sowell Financial Services LLC Purchases 53,077 Shares of MBX Biosciences, Inc. $MBX
MarketBeat ·
- MBX Biosciences appoints Peter Radovich to board as independent director By Investing.com
Investing.com South Africa ·
- MBX Biosciences to Participate in Upcoming November Investor Conferences
Yahoo Finance ·
- Is MBX Biosciences (MBX) Still Undervalued After Its Pullback From A Strong 1 Year Run?
Yahoo Finance ·
MBX Biosciences, Inc. key financials
| USD | 2025 | 2024 | 2023 |
|---|---|---|---|
| Net income | -$87.0M | -$61.9M | -$32.6M |
| Diluted EPS | $-2.38 | $-5.82 | $-31.96 |
| Total assets (year end) | $385.1M | $268.5M | $84.2M |
| Cash and equivalents (year end) | $75.3M | $49.4M | $30.5M |
Calendar-year figures as reported to the SEC in XBRL filings.
Recent SEC filings
About MBX Biosciences, Inc.
- Ticker
- MBX (Nasdaq)
- Industry
- Pharmaceutical Preparations
- Headquarters
- Carmel, IN
- Incorporated in
- DE
- Fiscal year end
- December 31
- SEC CIK
- 1776111
Frequently asked questions
What exchange is MBX Biosciences, Inc. listed on?
MBX Biosciences, Inc. trades on the Nasdaq under the ticker symbol MBX.
What industry is MBX Biosciences, Inc. in?
MBX Biosciences, Inc. is classified by the SEC under "Pharmaceutical Preparations", part of the Healthcare sector on StockTweeting.
Where is MBX Biosciences, Inc. headquartered?
MBX Biosciences, Inc.'s business address on file with the SEC is in Carmel, IN.
When does MBX Biosciences, Inc.'s fiscal year end?
MBX Biosciences, Inc.'s fiscal year ends on December 31.